Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
29.91
-0.15 (-0.50%)
Jul 18, 2025, 2:45 PM CST
SHE:301206 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 1,636 | 160.29 | 108.81 | 489.04 | 515.72 | 224.97 | Upgrade |
Short-Term Investments | - | 2,670 | - | - | - | - | Upgrade |
Trading Asset Securities | 659.8 | - | - | - | 0.33 | - | Upgrade |
Cash & Short-Term Investments | 2,296 | 2,830 | 108.81 | 489.04 | 516.05 | 224.97 | Upgrade |
Cash Growth | 2158.85% | 2501.17% | -77.75% | -5.23% | 129.38% | 56.71% | Upgrade |
Accounts Receivable | 104.47 | 122.37 | 80.93 | 51.11 | 141.36 | 70.93 | Upgrade |
Other Receivables | 1.94 | 277.58 | 6.55 | 12.82 | 21.11 | 8.88 | Upgrade |
Receivables | 106.41 | 399.95 | 87.48 | 63.94 | 162.47 | 79.81 | Upgrade |
Inventory | 158.84 | 142.71 | 104.33 | 96.77 | 112.16 | 68.21 | Upgrade |
Other Current Assets | 372.49 | 15.05 | 21.2 | 19.62 | 14.95 | 5.68 | Upgrade |
Total Current Assets | 2,933 | 3,388 | 321.81 | 669.37 | 805.62 | 378.67 | Upgrade |
Property, Plant & Equipment | 1,053 | 1,047 | 987.27 | 952.98 | 770.61 | 364.31 | Upgrade |
Long-Term Investments | 52.7 | 53.18 | 56.01 | 60.16 | - | - | Upgrade |
Other Intangible Assets | 46.15 | 46.43 | 47.58 | 48.73 | 49.14 | 30.15 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | - | 2.52 | 2.41 | Upgrade |
Other Long-Term Assets | 665.92 | 270.33 | 3,395 | 3,139 | 6.27 | 5.86 | Upgrade |
Total Assets | 4,752 | 4,805 | 4,808 | 4,870 | 1,634 | 781.39 | Upgrade |
Accounts Payable | 170.76 | 175.7 | 208.57 | 184.31 | 542.47 | 238.85 | Upgrade |
Accrued Expenses | 5.29 | 8.65 | 7.69 | 9.3 | 6.71 | 4.18 | Upgrade |
Current Income Taxes Payable | 13.5 | 0 | - | - | 3.4 | 4.36 | Upgrade |
Current Unearned Revenue | 6.02 | 4.82 | 5.18 | 4.22 | 11.43 | 11.11 | Upgrade |
Other Current Liabilities | 2.57 | 54.51 | 2.75 | 9.68 | 0.8 | 0.4 | Upgrade |
Total Current Liabilities | 198.13 | 243.67 | 224.2 | 207.51 | 564.81 | 258.89 | Upgrade |
Long-Term Unearned Revenue | 3.24 | 3.51 | 4.59 | 0.86 | 0.99 | 1.22 | Upgrade |
Long-Term Deferred Tax Liabilities | 57.53 | 66.87 | 43.61 | 40.78 | 23.03 | 11.36 | Upgrade |
Total Liabilities | 258.9 | 314.04 | 272.4 | 249.14 | 588.83 | 271.48 | Upgrade |
Common Stock | 202.33 | 202.33 | 202.33 | 202.33 | 101.16 | 101.16 | Upgrade |
Additional Paid-In Capital | 3,518 | 3,518 | 3,518 | 3,518 | 72.13 | 72.13 | Upgrade |
Retained Earnings | 813.79 | 788.87 | 815.19 | 900.84 | 872.03 | 336.62 | Upgrade |
Treasury Stock | -41.48 | -17.6 | - | - | - | - | Upgrade |
Shareholders' Equity | 4,493 | 4,491 | 4,535 | 4,621 | 1,045 | 509.91 | Upgrade |
Total Liabilities & Equity | 4,752 | 4,805 | 4,808 | 4,870 | 1,634 | 781.39 | Upgrade |
Net Cash (Debt) | 2,296 | 2,830 | 108.81 | 489.04 | 516.05 | 224.97 | Upgrade |
Net Cash Growth | 2158.85% | 2501.17% | -77.75% | -5.23% | 129.38% | 56.71% | Upgrade |
Net Cash Per Share | 11.30 | 14.02 | 0.54 | 2.45 | 3.40 | 1.48 | Upgrade |
Filing Date Shares Outstanding | 207.62 | 200.45 | 202.33 | 202.33 | 202.33 | 151.74 | Upgrade |
Total Common Shares Outstanding | 207.62 | 200.45 | 202.33 | 202.33 | 151.74 | 151.74 | Upgrade |
Working Capital | 2,735 | 3,144 | 97.62 | 461.86 | 240.81 | 119.78 | Upgrade |
Book Value Per Share | 21.64 | 22.41 | 22.41 | 22.84 | 6.89 | 3.36 | Upgrade |
Tangible Book Value | 4,446 | 4,445 | 4,488 | 4,572 | 996.19 | 479.77 | Upgrade |
Tangible Book Value Per Share | 21.41 | 22.17 | 22.18 | 22.60 | 6.56 | 3.16 | Upgrade |
Buildings | - | 215.87 | 172.81 | 138.83 | 64.98 | 62.02 | Upgrade |
Machinery | - | 994.69 | 864.93 | 786.97 | 410.28 | 257.62 | Upgrade |
Construction In Progress | - | 48.65 | 103.69 | 125.13 | 357.27 | 82.27 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.